Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III

Journal of Medical Genetics

Volumn 40, Issue 10, 2003, Pages 767-772

  Ness, S L ^a   Ben Yosef, T ^b   Bar Lev, A ^a   Madeo, A C ^b   Brewer, C C ^b   Avraham, K B ^c   Kornreich, R ^a   Desnick, R J ^a   Willner, J P ^a   Friedman, T B ^b   Griffith, A J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; ETHNOLOGY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; GENOTYPE; HAPLOTYPE; HEALTH SURVEY; HEARING IMPAIRMENT; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; JEW; MALE; MEDICAL RECORD; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATIENT CODING; PHENOTYPE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SEQUENCE ANALYSIS; USHER SYNDROME; USHER SYNDROME TYPE III; VESTIBULAR DISORDER; VISUAL DISORDER;

EID: 0142209180     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.10.767     Document Type: Article

References (29)

1. Vernon M. Usher's syndrome-deafness and progressive blindness. Clinical cases, prevention, theory and literature survey. J Chronic Dis 1969;22:133-51.
2. Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001;2:271-97.
3. Smith RJ, Berlin CI, Hejtmancik JF, Keats BJ, Kimberling WJ, Lewis RA, Moller CG, Pelias MZ, Tranebjaerg L. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet 1994;50:32-8.
4. Pakarinen L, Karjalainen S, Simola KO, Laippala P, Kaitalo H. Usher's syndrome type 3 in Finland. Laryngoscope 1995;105:613-17.
5. Liu XZ, Hope C, Walsh J, Newton V, Ke XM, Liang CY, Xu LR, Zhou JM, Trump D, Steel KP, Bundey S, Brown SD. Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet 1998;63:909-12.
6. Bork JM, Morell RJ, Khan S, Riazuddin S, Wilcox ER, Friedman TB, Griffith AJ. Clinical presentation of DFNB12 and Usher syndrome type 1D. Adv Otorhinolaryngol 2002;61:145-52.
7. Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ, Ohliger SJ, Riazuddin S, Morell RJ, Khan S, Riazuddin S, Kremer H, van Hauwe P, Moller CG, Cremers CW, Ayuso C, Heckenlively JR, Rohrschneider K, Spandau U, Greenberg J, Ramesar R, Reardon W, Bitoun P, Millan J, Legge R, Friedman TB, Kimberling WJ. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002;71:262-75.
8. Pakarinen L, Tuppurainen K, Laippala P, Mantyjarvi M, Puhakka H. The ophthalmological course of Usher syndrome type III. Int Ophthalmol 1995;19:307-11.
9. Tsilou ET, Rubin BI, Caruso RC, Reed GF, Pikus A, Hejtmancik JF, Iwata F, Redman JB, Kaiser-Kupfer MI. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 2002;80:196-201.
10. Joensuu T, Hamalainen R, Yuan B, Johnson C, Tegelberg S, Gasparini P, Zelante L, Pirvola U, Pakarinen L, Lehesjoki AE, de la Chapelle A, Sankila EM. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet 2001;69:673-84.
11. Adato A, Vreugde S, Joensuu T, Avidan N, Hamalainen R, Belenkiy O, Olender T, Bonne-Tamir B, Ben-Asher E, Espinos C, Millan JM, Lehesjoki AE, Flannery JG, Avraham KB, Pietrokovski S, Sankila EM, Beckmann JS, Lancet D. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet 2002;10:339-50.
12. Fields RR, Zhou G, Huang D, Davis JR, Moller C, Jacobson SG, Kimberling WJ, Sumegi J. Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet 2002;71:607-17.
13. European Working Group on Genetics of Hearing Impairment. Infoletter, 2nd ed, 1996. http://web.unife.it/progetti/gendeaf/hear/infoletters/Infro_02. pdf.
14. Meulenbelt I, Droog S, Trommelen GJ, Boomsma DI, Slagboom PE. High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations. Am J Hum Genet 1995;57:1252-4.
15. Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Volcker HE. (Indications and prognosis of cataract surgery in patients with retinitis pigmentosa). Ophthalmologe 1996;93:168-76.
16. Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Volcker HE. (Complicated cataracts in various forms of retinitis pigmentosa. Type and incidence). Ophthalmologe 1997;94:642-6.
17. Heckenlively J. The frequency of posterior subcapsular cataract in the hereditary retinal degenerations. Am J Ophthalmol 1982;93:733-8.
18. Newsome DA, Stark WJ Jr, Maumenee IH. Cataract extraction and intraocular lens implantation in patients with retinitis pigmentosa or Usher's syndrome. Arch Ophthalmol 1986;104:852-4.
19. Morell RJ, Kim HJ, Hood LJ, Goforth L, Friderici K, Fisher R, Van Camp G, Berlin CI, Oddoux C, Ostrer H, Keats B, Friedman TB. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339:1500-5.
20. Ben-Yosef T, Ness SL, Madeo AC, Bar-Lev A, Wolfman JH, Ahmed ZM, Desnick RJ, Willner JP, Avraham KB, Ostrer H, Oddoux C, Griffith AJ, Friedman TB. A prevalent founder mutation of PCDH15 among Ashkenazi Jews with the Type 1 Usher syndrome. N Engl J Med 2003;348:1664-70.
21. Lerer I, Sagi M, Malamud E, Levi H, Raas-Rothschild A, Abeliovich D. Contribution of connexin 26 mutations to nonsyndromic deafness in Ashkenazi patients and the variable phenotypic effect of the mutation 167delT. Am J Med Genet 2000;95:53-6.
22. Sobe T, Erlich P, Berry A, Korostichevsky M, Vreugde S, Avraham KB, Bonne-Tamir B, Shohat M. High frequency of the deafness-associated 167delT mutation in the connexin 26 (GJB2) gene in Israeli Ashkenazim. Am J Med Genet 1999;86:499-500.
23. Spandau UH, Rohrschneider K. Prevalence and geographical distribution of Usher syndrome in Germany. Graefes Arch Clin Exp Ophthalmol 2002;240:495-8.
24. Bereketoglu M, Avsar EU, Turan O, Afrashi F, Apaydin F. (The incidence of Usher's syndrome and its clinical types). Kulak Burun Bogaz Ihtis Derg 2002;9:15-20.
25. Keats BJ, Corey DP. The Usher syndromes. Am J Med Genet 1999;89:158-66.
26. Rosenberg T, Haim M, Hauch AM, Parving A. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet 1997;51:314-21.
27. van Aarem A, Pinckers AJ, Kimberling WJ, Huygen PL, Bleeker-Wagemakers EM, Cremers CW. Stable and progressive hearing loss in type 2A Usher's syndrome. Ann Otol Rhinol Laryngol 1996;105:962-7.
28. Wagenaar M, van Aarem A, Huygen P, Pieke-Dahl S, Kimberling W, Cremers C. Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg 1999;125:441-5.
29. Reisser CF, Kimberling WJ, Otterstedde CR. Hearing loss in Usher syndrome type II is nonprogressive. Ann Otol Rhinol Laryngol 2002;111:1108-11.